SW480E

Cat.No.: CSC-C9730L

Species: Homo sapiens (Human)

Source: Intestine; Colon

Morphology: epithelial

Culture Properties: monolayer

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9730L
Description
Histopathology: colorectal carcinoma
Species
Homo sapiens (Human)
Source
Intestine; Colon
Culture Properties
monolayer
Morphology
epithelial
STR DNA Profile
D3S1358: 15
vWA: 16
FGA: 24
Amelogenin: X
TH01: 8
TPOX: 11
CSF1P0: 13,14
D5S818: 13
D13S317: 12
D7S820: 8
Disease
Colon Adenocarcinoma
Quality Control
Tests for mycoplasma, bacteria and fungi were negative
Storage and Shipping
Frozen with 52.5% RPMI-1640, 40% FBS, 7.5% DMSO at about 4-5 x 10^6 cells/ampoule
Shipping Condition: Room Temperature
Synonyms
SW480 E8
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

SW480E is a variation or epithelial enriched subpopulation from the human colorectal adenocarcinoma cell line SW480, which was obtained from a primary colon tumor of a Duke's B colorectal cancer patient. Similar to the ancestral SW480 line, SW480E maintains key molecular and phenotypic characteristics associated with colorectal cancer progression including dysregulated Wnt/β-catenin signaling, high proliferative potential and tumor-related epithelial features.

The SW480E cells are commonly employed in the cancer biology field to study the molecular pathways of tumor cell proliferation, epithelial-mesenchymal transition (EMT), migration, invasion, and treatment resistance. Because of their epithelial-like appearance and persistent in vitro growth features, these cells are particularly useful for studies on cell adhesion, signaling pathway modulation, and interactions between tumor cells and the tumor microenvironment.

Recent research using SW480E or related SW480 sublines have focused on cancer stem cell heterogeneity, metastatic behavior, apoptosis regulation, and responses to chemotherapeutic drugs or targeted therapies. This cell line is often used in tests such as proliferative assays, wound healing, trans-well invasion, colony formation, flow cytometry, and transcriptome profiling.

Impact of Bupivacaine on Malignant Proliferation, Apoptosis and Autophagy of Human Colorectal Cancer SW480 Cells

While local anesthetics like Bupivacaine exhibit anti-cancer properties in various malignancies, their effects in colorectal cancer (CRC) remain unclear. Liu's team investigated Bupivacaine's impact on CRC cell proliferation, migration, and apoptosis.

Treatment with 1 mM Bupivacaine for 24 or 48 hours significantly inhibited the viability of CRC cell lines (SW480, SW620), with a more pronounced effect at 48 hours (Fig. 1a-d). Importantly, this concentration did not affect the viability of normal colon cells (FHC) (Fig. 1e-f). Bupivacaine also significantly impaired CRC cell migration in scratch assays (Fig. 2a-d).

Furthermore, Bupivacaine induced apoptosis in a time-dependent manner (Fig. 3a-b), mechanistically linked to the downregulation of the anti-apoptotic protein Bcl-2 and the upregulation of pro-apoptotic proteins (Bax, cleaved caspase-3) (Fig. 3c-f). Collectively, these data suggest that Bupivacaine selectively suppresses CRC progression by inhibiting proliferation and migration while promoting apoptosis.

Bupivacaine Inhibited CRC Cell Proliferation

Fig. 1. Bupivacaine Inhibited CRC Cell Proliferation (Liu B, Yan X, et al., 2021).

Bupivacaine Inhibited CRC Cell Migration

Fig. 2. Bupivacaine Inhibited CRC Cell Migration (Liu B, Yan X, et al., 2021).

Bupivacaine Promoted CRC Cell Apoptosis

Fig. 3. Bupivacaine Promoted CRC Cell Apoptosis (Liu B, Yan X, et al., 2021).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products